Posts by Ting Sung

National Rare Disease Day – February 28, 2023

National Rare Disease Day is observed on February 29th, the rarest day of the year, or on this year on February 28th. This year’s theme is focused on health equity. As rare diseases affect small numbers of patients, understanding the diversity of patients and how it affects presentation, diagnosis, and treatment is crucial for addressing…

Read More

Can Digital Technologies Improve Oncology Care?

Oncology - Digital tools

By: Dennis Chang, Ph.D., managing director, Tracy McCarty, senior principal, Daniyal Tariq, senior associate, and Natalie Thovmasian, Ph.D., senior principal Digital technologies are becoming more prevalent across the healthcare field, and new applications in oncology have begun to emerge. These applications span a wide range, operating at the level of populations or for individuals, and…

Read More

China’s Oncology Pipeline: 2022 Recap and Future Outlook

China's oncology pipeline: 2022 Recap and future outlook

By: Dennis Chang, Ph.D., managing director and Letao Fan, Ph.D., senior associate In 2022, China was at the center of a significant amount of international news coverage, most of which focused on the ongoing COVID-19 pandemic, including widespread lockdowns. These reports painted a picture of disruption to society and the economy. However, China’s oncology pipeline…

Read More

Highlights of ESMO Congress 2022

ESMO Highlights

By: Dennis Chang, Ph.D., Alissa Clear Ph.D., Krisstel Gomez, Andrew Hayden, Claudia Lanauze-Torres, Ph.D., and Natalie Thovmasian, Ph.D. There were over 3000+ abstracts at this year’s conference. In the following article, our Clarion oncology team shares key highlights from ESMO 2022. DETERMINING THE RIGHT PLACE FOR IMMUNOTHERAPY IN EARLY-STAGE DISEASE Many IO experts have long…

Read More

Is Clarion the right place to advance your career?

Find out more about joining Clarion’s team of innovation advisors.

A life sciences strategy and organizational consultancy that collaborates with its clients to envision, craft and enable growth through innovation and leadership.